NICE recommends pembrolizumab for Hodgkin lymphoma
New treatment available for relapsed or refractory classical Hodgkin lymphoma.
Read the latest news and views from Lymphoma Action.
Use the drop down filter to find the most relevant news for you.
New treatment available for relapsed or refractory classical Hodgkin lymphoma.
Many people with lymphoma experience fatigue – an exhaustion that can be mental, physical and emotional.
We want to thank everyone who ran for #TeamLymphoma on Sunday 21 April.
A booster is being offered again this spring to protect the most vulnerable from the effects of COVID-19.
Booking is now open for one of our leading events for healthcare professionals working in the field of lymphoma.
Support our work to make sure no one has to face lymphoma alone.
Raising awareness of the unique challenges faced by young people living with cancer.
Information about the extra precautions people affected by lymphoma might need to consider.
Explaining why lymphomas are classed as a type of blood cancer.